Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-002927
Filing Date
2025-01-07
Accepted
2025-01-07 16:50:41
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3988
  Complete submission text file 0000950170-25-002927.txt   5762
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Issuer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address
Graham Juan (Reporting) CIK: 0001879223 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33407 | Film No.: 25515487